VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Nkarta Therapeutics

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 90 out of 100

Nkarta Inc. - Natural Killer Cell Therapy Autoimmune Care

Also known as Nkarta, Inc

  • Biotech & therapeutics
Business model
B2B
Legal name
Nkarta, Inc
Open relationship map
Claim, correct or request removal

Record updated 29 September 2026

About

Learn about Nkarta, a clinical stage biotechnology company advancing the development of natural killer therapies to treat autoimmune disease.

Funding snapshot

Total raised
$43.9MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
Latest round
Round, $43.9M2019-08-27

Funding rounds

Round, 2019
$43.9M2019-08-27, SEC form D sold, 13 investors
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy